M R13
Pill imprint M R13 has been identified as Risperidone 3 mg.
Risperidone is used in the treatment of schizophrenia; bipolar disorder; mania; schizoaffective disorder; autism (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy.
Risperidone 3 mg is not subject to the Controlled Substances Act.
See also related documents.
Risperidone Images
- Imprint:
-
M
R13 - Strength:
- 3 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
docusate sodium
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium benzoate
sodium lauryl sulfate
titanium dioxide
triacetin
- Drug Class:
- Atypical antipsychotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3513
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0464 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More Risperidone resources
- risperidone
- Risperidone (Wolters Kluwer)
- Risperidone Orally Disintegrating Tablets (Wolters Kluwer)
- Risperidone Solution (Wolters Kluwer)
- Risperidone Tablets (Wolters Kluwer)
- risperidone (Cerner Multum)
- risperidone (Micromedex) - Includes Dosage Information
- risperidone Intramuscular (Micromedex) - Includes Dosage Information
- Risperidone (AHFS DI)
- Risperidone (FDA)
- Risperidone Oral Solution (FDA)
- Risperidone Orally Disintegrating (FDA)
- Risperidone (Wolters Kluwer)


